Process Translation & Execution Engineer, Foundry

Biopharma Careers; Lebanon (KY); On-site; USD 66,000 - 172,000; Full time

Benefits offered by this job

401(k) plan

Pension

Medical benefits

Vacation benefits

Job summary

Lilly in Lebanon, Indiana, is seeking passionate engineers to join the PTE team and help bring the Lilly Medicine Foundry’s vision to life. You will contribute to transferring chemical processes from development to pilot scale, ensuring readiness for clinical manufacturing and supporting phase-appropriate control strategies.

Working across development, safety, and quality teams, you will apply process know-how to crystallization, filtration, and scale‑up challenges while upholding cGMP and FDA

Qualifications

• BS or MS in Chemical Engineering required.
• 4+ years of industry experience in pharmaceutical process development, pilot plant operations, or chemical manufacturing.
• Authorized to work in the United States full-time; Lilly does not sponsor visas.

Responsibilities

• Facilitate transfer of chemical processes from development to pilot plant operations, enabling early-phase cGMP manufacturing for clinical trial supply.
• Operate kilo-scale equipment (multi-purpose reactors, filtration systems, drying equipment).
• Apply heat/mass transfer, reaction kinetics, and thermodynamics to scale-up and equipment sizing.

Skills

Chemical Engineering

Pilot Plant Operations

Process Development

Crystallization

Filtration

cGMP

Education

BS in Chemical Engineering

MS in Chemical Engineering

Tools

DeltaV

Dynochem

Aspen

Electronic Lab Notebooks

Job description

Lilly in Lebanon, Indiana, is seeking passionate engineers to join the PTE team and help bring the Lilly Medicine Foundry’s vision to life. You will contribute to transferring chemical processes from development to pilot scale, ensuring readiness for clinical manufacturing and supporting phase-appropriate control strategies.

Working across development, safety, and quality teams, you will apply process know-how to crystallization, filtration, and scale‑up challenges while upholding cGMP and FDA